相似文献
1
Systems-Wide Approaches in Induced Pluripotent Stem Cell Models.
Annu Rev Pathol. 2019 Jan 24;14:395-419. doi: 10.1146/annurev-pathmechdis-012418-013046. Epub 2018 Oct 31.
2
Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine.
BMC Genomics. 2016 Jul 11;17:488. doi: 10.1186/s12864-016-2809-9.
3
Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Brain Res. 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Epub 2015 Sep 28.
4
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
Int J Mol Sci. 2015 Aug 12;16(8):18894-922. doi: 10.3390/ijms160818894.
5
Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
Expert Rev Proteomics. 2012 Aug;9(4):379-99. doi: 10.1586/epr.12.30.
6
Self-organizing map of gene regulatory networks for cell phenotypes during reprogramming.
Comput Biol Chem. 2011 Aug 10;35(4):211-7. doi: 10.1016/j.compbiolchem.2011.05.002. Epub 2011 May 26.
7
Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Hum Reprod. 2015 Mar;30(3):737-48. doi: 10.1093/humrep/deu358. Epub 2015 Jan 12.
8
Preparation of iPSCs for Targeted Proteomic Analysis.
Methods Mol Biol. 2019;1994:131-139. doi: 10.1007/978-1-4939-9477-9_11.
9
Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
Adv Biol Regul. 2019 Jan;71:19-33. doi: 10.1016/j.jbior.2018.10.001. Epub 2018 Oct 10.
10
Primate iPS cells as tools for evolutionary analyses.
Stem Cell Res. 2014 May;12(3):622-9. doi: 10.1016/j.scr.2014.02.001. Epub 2014 Feb 8.
引用本文的文献
1
Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture.
Vet Sci. 2024 Dec 19;11(12):666. doi: 10.3390/vetsci11120666.
2
Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: "What Are the Tools Needed for the Job?" and "Do We Have Them?".
Cardiovasc Toxicol. 2024 May;24(5):435-471. doi: 10.1007/s12012-024-09850-9. Epub 2024 Mar 31.
3
Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation.
Stem Cell Res. 2023 Oct;72:103215. doi: 10.1016/j.scr.2023.103215. Epub 2023 Sep 27.
4
Statins improve endothelial function via suppression of epigenetic-driven EndMT.
Nat Cardiovasc Res. 2023 May;2(5):467-485. doi: 10.1038/s44161-023-00267-1. Epub 2023 May 8.
5
Elucidating effects of environmental exposure using human-induced pluripotent stem cell disease modeling.
EMBO Mol Med. 2022 Nov 8;14(11):e13260. doi: 10.15252/emmm.202013260. Epub 2022 Oct 26.
6
Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.
Cell. 2022 May 12;185(10):1676-1693.e23. doi: 10.1016/j.cell.2022.04.005. Epub 2022 Apr 29.
7
Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics.
Front Cardiovasc Med. 2022 Mar 10;9:851491. doi: 10.3389/fcvm.2022.851491. eCollection 2022.
8
Multi-Omic Approaches to Identify Genetic Factors in Metabolic Syndrome.
Compr Physiol. 2021 Dec 29;12(1):3045-3084. doi: 10.1002/cphy.c210010.
9
Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs.
Trends Genet. 2021 Dec;37(12):1109-1123. doi: 10.1016/j.tig.2021.08.009. Epub 2021 Sep 8.
10
Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity.
Front Pharmacol. 2021 Mar 10;12:613837. doi: 10.3389/fphar.2021.613837. eCollection 2021.
本文引用的文献
1
Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods.
Nat Biomed Eng. 2017 Oct;1(10):826-837. doi: 10.1038/s41551-017-0141-6. Epub 2017 Oct 3.
2
Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.
Development. 2018 Mar 8;145(5):dev156166. doi: 10.1242/dev.156166.
3
SETD7 Drives Cardiac Lineage Commitment through Stage-Specific Transcriptional Activation.
Cell Stem Cell. 2018 Mar 1;22(3):428-444.e5. doi: 10.1016/j.stem.2018.02.005.
4
Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.
Stem Cell Reports. 2018 Mar 13;10(3):808-821. doi: 10.1016/j.stemcr.2018.01.013. Epub 2018 Feb 15.
5
How many human proteoforms are there?
Nat Chem Biol. 2018 Feb 14;14(3):206-214. doi: 10.1038/nchembio.2576.
6
Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction.
Stem Cell Reports. 2018 Feb 13;10(2):422-435. doi: 10.1016/j.stemcr.2018.01.002. Epub 2018 Feb 1.
7
Mapping gene regulatory networks from single-cell omics data.
Brief Funct Genomics. 2018 Jul 1;17(4):246-254. doi: 10.1093/bfgp/elx046.
8
Integrated omics dissection of proteome dynamics during cardiac remodeling.
Nat Commun. 2018 Jan 9;9(1):120. doi: 10.1038/s41467-017-02467-3.
9
Molecular and functional variation in iPSC-derived sensory neurons.
Nat Genet. 2018 Jan;50(1):54-61. doi: 10.1038/s41588-017-0005-8. Epub 2017 Dec 11.
10
Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
Circulation. 2018 Mar 20;137(12):1270-1277. doi: 10.1161/CIRCULATIONAHA.117.029443. Epub 2017 Dec 8.
Zotero 插件